Polarx Biopharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Polarx Biopharmaceuticals, Inc..The latest application filed is for "compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds".

Company Profile

0.5.8

Polarx Biopharmaceuticals, Inc. - Wilmington DE
PolaRx Biopharmaceuticals, Inc. -
PolaRx Biopharmaceuticals Inc. - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds Grant 7,205,001 - Ellison , et al. April 17, 2	2007-04-17
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds Grant 7,179,493 - Ellison , et al. February 20, 2	2007-02-20
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds Grant 7,163,703 - Ellison , et al. January 16, 2	2007-01-16
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds Grant 7,132,116 - Ellison , et al. November 7, 2	2006-11-07
Compositions and methods for the treatment of Primary and metastatic neoplastic diseases using arsenic compounds App 20050191367 - Ellison, Ralph M. ; et al.	2005-09-01
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds App 20050100611 - Ellison, Ralph M. ; et al.	2005-05-12
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds Grant 6,875,451 - Ellison , et al. April 5, 2	2005-04-05
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds App 20040197420 - Ellison, Ralph M. ; et al.	2004-10-07
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds App 20040197421 - Ellison, Ralph M. ; et al.	2004-10-07
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds App 20040161475 - Ellison, Ralph M. ; et al.	2004-08-19
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds App 20040115283 - Ellison, Ralph M. ; et al.	2004-06-17
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds App 20040096518 - Ellison, Ralph M. ; et al.	2004-05-20
Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds App 20040047916 - Ellison, Ralph M. ; et al.	2004-03-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.